Pregled bibliografske jedinice broj: 1014643
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study // Journal of Clinical Medicine, 8 (2019), 8; 1132, 18 doi:10.3390/jcm8081132 (međunarodna recenzija, kratko priopcenje, znanstveni)
CROSBI ID: 1014643 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Catestatin in Acutely Decompensated Heart Failure
Patients: Insights from the CATSTAT-HF Study
Autori
Borovac, Josip Anđelo ; Glavaš, Duška ; Sušilović Grabovac, Zora ; Šupe Domić, Daniela ; D'Amario, Domenico ; Božić, Joško
Kolaboracija
CATSTAT-HF
Izvornik
Journal of Clinical Medicine (2304-6775) 8
(2019), 8;
1132, 18
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, znanstveni
Ključne riječi
acute myocardial infarction ; biomarkers ; catestatin ; coronary artery disease ; heart failure ; heart failure decompensation ; left ventricular ejection fraction ; troponin ; NT-proBNP ; NYHA functional class
Sažetak
The role of catestatin (CST) in acutely decompensated heart failure (ADHF) and myocardial infarction (MI) is poorly elucidated. Due to the implicated role of CST in the regulation of neurohumoral activity, the goals of the study were to determine CST serum levels among ninety consecutively enrolled ADHF patients, with respect to the MI history and left ventricular ejection fraction (LVEF) and to examine its association with clinical, echocardiographic, and laboratory parameters. CST levels were higher among ADHF patients with MI history, compared to those without (8.94 ± 6.39 vs. 4.90 ± 2.74 ng/mL, p = 0.001). CST serum levels did not differ among patients with reduced, midrange, and preserved LVEF (7.74 ± 5.64 vs. 5.75 ± 4.19 vs. 5.35 ± 2.77 ng/mL, p = 0.143, respectively). In the multivariable linear regression analysis, CST independently correlated with the NYHA class (β = 0.491, p < 0.001), waist-to-hip ratio (WHR) (β = −0.237, p = 0.026), HbA1c (β = −0.235, p = 0.027), LDL (β = −0.231, p = 0.029), non-HDL cholesterol (β = −0.237, p = 0.026), hs-cTnI (β = −0.221, p = 0.030), and the admission and resting heart rate (β = −0.201, p = 0.036 and β = −0.242, p = 0.030), and was in positive association with most echocardiographic parameters. In conclusion, CST levels were increased in ADHF patients with MI and were overall associated with a favorable cardiometabolic profile but at the same time reflected advanced symptomatic burden (CATSTAT-HF ClinicalTrials.gov number, NCT03389386).
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split,
Sveučilište u Splitu,
Sveučilište u Splitu Sveučilišni odjel zdravstvenih studija
Profili:
Duška Glavaš
(autor)
Josip Anđelo Borovac
(autor)
Joško Božić
(autor)
Daniela Šupe Domić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus